Skip to main content
Caplight Logo









Lucent BioSciences

Lucent BioSciences

Private
West Vancouver, British ColumbiaEnergy & Sustainabilityhttps://lucentbiosciences.com/

Last Round

Grant

Nov 7, 2023

Total Funding Raised

$7.89M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lucent BioSciences is an agritech company that develops sustainable, non-polluting crop nutrition products from upcycled plant-based materials.

Sector

Energy & Sustainability

Verticals

Circular Economy, Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

micronutrient fertilizerslow-release fertilizersustainable fertilizerseed coatingagritechbiofertilizerregenerative agriculturecrop nutritionsoil healthupcycled materialscircular economycrop inputsbio-activated fertilizercustom fertilizer formulationmicroplastic-free

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucent BioSciences Comparables

Compare Lucent BioSciences with similar companies based on industry and business-model similarity.

Lucent BioSciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sound
78%
Verdesian Life Sciences
78%
Prospect Growth
77%

Lucent BioSciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 7, 2023
GrantMar 15, 2023
SeedNov 23, 2021
GrantMar 31, 2021
GrantMar 3, 2020

Key People

Founding team and executive leadership

Jason McNamee

Lucent Biosciences, Chief Operations Officer, Senior Biogeoscientist And Founder.

Founding Team

Michael Riedijk

Founder, CEO

Founding Team

Lucent BioSciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 63, 4.6x the trailing average.

  • Jul 20, 2026

    Open roles increased to 63, 233% of headcount.

Recent news

Latest coverage and updates

  • receives_financingSep 17, 2026

    Lucent BioSciences, Inc. received financing of $1.98M in federal funding on Sep 17th '26.

  • partners_withSep 16, 2026

    In a project applying biodegradable biopolymer technology to controlled-release nitrogen, Lucent BioSciences, Inc. is also partnering with A&L Canada Laboratories Inc..

  • partners_withSep 16, 2026

    Lucent BioSciences, Inc. is partnering with SFU group on a project applying biodegradable biopolymer technology to controlled-release nitrogen.

  • partners_withSep 16, 2026

    As part of a project applying biodegradable biopolymer technology to controlled-release nitrogen, Lucent BioSciences, Inc. is partnering with Bureau Veritas Group.

  • partners_withSep 16, 2026

    Lucent BioSciences, Inc. partnered with 4d Labs on Jul 1st '22.

Lucent BioSciences Filings

Explore SEC and related filing metadata, where available.

Lucent BioSciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lucent BioSciences's valuation, stock price, and market status.

Is Lucent BioSciences a public or private company?

Lucent BioSciences is a private company.

What is the current stock price of Lucent BioSciences?

Lucent BioSciences is a private company, so its shares have no public market price. Caplight tracks Lucent BioSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Lucent BioSciences worth (valuation)?

Valuation information for Lucent BioSciences is not publicly available.

Can I buy Lucent BioSciences stock?

Lucent BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Lucent BioSciences's last funding round?

Lucent BioSciences's most recent funding round was Grant on November 7, 2023.

Who are the main investors in Lucent BioSciences?

Key investors in Lucent BioSciences include Pacific Economic Development Canada, Protein Industries Canada, Government of Canada, Conexus Venture Capital, Innovate BC.

Will Lucent BioSciences IPO soon?

No public IPO plans have been announced for Lucent BioSciences.

How can I track Lucent BioSciences secondary market activity?

Caplight tracks bids, offers, and trades in Lucent BioSciences's shares on secondary markets.

Firmographic Details

HeadquartersWest Vancouver, British Columbia
Employee Range21
Year Founded2014
Last FundingNov 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?